Targeted Market Small team size (2-10 employees) and focused product niche in MIS bone and marrow harvesting presents a lean, specialized sales approach. Opportunity to position as a high-value, specialized supplier to orthopedic surgeons and trauma centers seeking minimally invasive graft solutions.

Innovation Focus Recent launches of MIS Bone Harvesting, MIS Debridement/Curettage, and MIS Autograft Delivery indicate a trajectory toward less invasive procedures. Upsell to surgeons and hospitals looking to upgrade to minimally invasive graft delivery systems and associated disposables.

Expansion Potential Publicized product expansions for harvesting from smaller anatomies (calcaneus, distal radius) suggest targeting small to mid-size orthopedic centers and academic hospitals that treat complex cases with limited access sites. Growth opportunities through strategic partnerships and regional distributors.

Financial Viability Current revenue range and $5M funding signal a company in growth mode with budgetary flexibility for procurement of MIS instrumentation, consumables, training, and after-sales support.

Competitive Positioning Operating in a space dominated by larger players, Avitus Orthopaedics can emphasize agility, specialized solutions, and faster adoption cycles. Potential to win through targeted outreach to surgeons focusing on pseudomembrane and biofilm debridement capabilities and autograft delivery efficiency.